North America and Europe Dermal Fillers Market, by Product Type (Absorbable, Non-absorbable) By Ingredients (Hyaluronic acid, Poly-L-Lactic acid, Calcium Hydroxylapatite, Polymethylmethacrylate, Collagen), By Distribution channel (Retail pharmacies and drug stores, Clinics and Hospital pharmacies, Online sales), and by Region (North America, Western Europe, Eastern Europe)-

Published In : May 2023

Code : CMI3522

Pages :140

Formats :

Excel and PDF

Industry : Medical Devices

Leading Companies

North America and Europe Dermal Fillers Market Cross Sectional Analysis:

Launches of new online pharmacies in the Europe region are expected to boost demand for dermal fillers in these regions. For instance, in January 2021, the organic pharmacy, a London based wellness retail store which already have presence in Europe at Germany, Sweden, Denmark, and Portugal, opened a flagship concept store in Marylebon, U.K.

North America and Europe Dermal Fillers Market : Key Developments

Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio.

For instance, in January 2020, Revance Therapeutics, Inc. a U.S. based aesthetics company signed an agreement with TEOXANE SA, a U.K.-based COSMECEUTICAL company for distribution of TEOXANE SA’s Resilient Hyaluronic Acid technology in the U.S.

In January 2020, Histogen, Inc., a U.S.-based company, expanded its partnership with Allergan, Inc. U.S.-based pharmaceutical company, under which Allergan acquired exclusive rights to incorporate and commercialize Histogen's cell conditioned media in microdermabrasion therapies and exclusive rights to new Histogen intellectual property in the aesthetic field.

North America and Europe Dermal Fillers Market - Key Players

Major players operating in the North America and Europe Dermal Fillers Market include Galderma Pharma S.A., Sinclair Pharma plc., Allergan Plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH, and Laboratoires Vivacy SAS.